TipRanks
Shl Telemedicine Ltd. (GB:0QMX)
LSE:0QMX

Shl Telemedicine (0QMX) Stock Statistics & Valuation Metrics

― Followers

Total Valuation

Shl Telemedicine has a market cap or net worth of CHF38.35M. The enterprise value is CHF30.86M.
Market CapCHF38.35M
Enterprise ValueCHF30.86M

Share Statistics

Shl Telemedicine has 37,059,944 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,059,944
Owned by Insiders―
Owned by Institutions<0.01%

Financial Efficiency

Shl Telemedicine’s return on equity (ROE) is -0.37 and return on invested capital (ROIC) is -7.90%.
Return on Equity (ROE)-0.37
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-7.90%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee116.89K
Profits Per Employee-29.23K
Employee Count526
Asset Turnover0.73
Inventory Turnover25.51

Valuation Ratios

The current PE Ratio of Shl Telemedicine is ―. Shl Telemedicine’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.52
PB Ratio0.73
Price to FCF-9.17
Price to Operating Cash Flow-55.64
PEG Ratio0.04

Income Statement

In the last 12 months, Shl Telemedicine had revenue of 61.49M and earned -16.11M in profits. Earnings per share was -0.76.
Revenue61.49M
Gross Profit22.89M
Operating Income-4.73M
Pretax Income-15.18M
Net Income-16.11M
EBITDA3.28M
Earnings Per Share (EPS)-0.76

Cash Flow

In the last 12 months, operating cash flow was -869.38K and capital expenditures -1.35M, giving a free cash flow of -2.22M billion.
Operating Cash Flow-869.38K
Free Cash Flow-2.22M
Free Cash Flow per Share-0.06

Dividends & Yields

Shl Telemedicine pays an annual dividend of CHF1.001, resulting in a dividend yield of 9.62%
Dividend Per ShareCHF1.001
Dividend Yield9.62%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―

Stock Price Statistics

Beta0.35
52-Week Price Change-52.88%
50-Day Moving Average1.07
200-Day Moving Average1.09
Relative Strength Index (RSI)61.64
Average Volume (3m)0.00

Important Dates

Shl Telemedicine upcoming earnings date is Apr 14, 2027, TBA (Confirmed).
Last Earnings DateSep 9, 2026
Next Earnings DateApr 14, 2027
Ex-Dividend Date―

Financial Position

Shl Telemedicine as a current ratio of 1.25, with Debt / Equity ratio of 24.81%
Current Ratio1.25
Quick Ratio1.20
Debt to Market Cap0.29
Net Debt to EBITDA-3.71
Interest Coverage Ratio-3.82

Taxes

In the past 12 months, Shl Telemedicine has paid 927.10K in taxes.
Income Tax927.10K
Effective Tax Rate-0.06

Enterprise Valuation

Shl Telemedicine EV to EBITDA ratio is 6.01, with an EV/FCF ratio of -5.67.
EV to Sales0.32
EV to EBITDA6.01
EV to Free Cash Flow-5.67
EV to Operating Cash Flow-10.36

Balance Sheet

Shl Telemedicine has CHF19.38M in cash and marketable securities with CHF10.75M in debt, giving a net cash position of CHF8.63M billion.
Cash & Marketable SecuritiesCHF19.38M
Total DebtCHF10.75M
Net CashCHF8.63M
Net Cash Per ShareCHF0.23
Tangible Book Value Per ShareCHF0.52

Margins

Gross margin is 45.94%, with operating margin of -7.69%, and net profit margin of -26.20%.
Gross Margin45.94%
Operating Margin-7.69%
Pretax Margin-24.69%
Net Profit Margin-26.20%
EBITDA Margin5.34%
EBIT Margin-7.69%

Analyst Forecast

The average price target for Shl Telemedicine is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-0.04%
EPS Growth Forecast46.39%

Scores

Smart ScoreN/A
AI Score―